Senior adviser to the executive VP and coverage expert Katherine Hempstead, who worked on a new online tool that allows users to track individual market entry for the 2019 plan year by state, county and carrier, says the data shows insurers are stickin…
Exchange consumers are dropping coverage over time, but it’s not as bad as last year. That news and other headlines from around the web.
After President Trump announced his pick of Brett Kavanaugh for his Supreme Court pick, all eyes pointed to what it could mean for major healthcare decision including the Affordable Care Act and the future of abortion laws.
Putting politics aside, HHS Secretary Alex Azar spoke to a group of 340B hospital representatives on Monday. He said the program needs changes, but he also reiterated the administration’s commitment to lowering drug prices.
HHS Secretary Alex Azar was speaking Monday at the summer conference for the 340B Coalition, which represents programs and providers that support the drug discount program. It came as President Trump threatened action against companies like Pfizer for …
Cerner will become a minority owner in Lumeris’ parent company as part of a 10-year strategic partnership focused on value-based care payment arrangements, particularly in the Medicare Advantage space. The two companies plan to release a new joint offe…
During an event hosted by the American Enterprise Institute examining the future of the ACA, healthcare experts said they don’t expect insurers to experience a delay in risk adjustment payouts.
Over the weekend, CMS announced it was freezing billions in risk adjustment payments to insurers on the ACA marketplace, citing a New Mexico court ruling from March. AHIP said the decision would create more market uncertainty and increase premiums.
The Centers for Medicare & Medicaid Services is pushing back the deadline to participate in the Trump administration’s new bundled payment program, and Vermont is planning to regulate the White House’s recently announced associated health plans.
Mark Linthicum, director of scientific communications at IVI, discusses the problems with measuring the “value” in value-based payment arrangements. He also has some recommendations for CMS.
